These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 2969067
21. Hepatitis B vaccine. Eder G, McDonel JL, Dorner F. Prog Liver Dis; 1986; 8():367-94. PubMed ID: 3520664 [No Abstract] [Full Text] [Related]
22. [Seroprevalence of hepatitis B virus and human immunodeficiency virus infections in the personnel of a general hospital]. Sánchez Casado ML, Calderón Morales MT, Muñoz Sanz A, Iradier Barrios C. Med Clin (Barc); 1988 Nov 12; 91(16):637. PubMed ID: 3230966 [No Abstract] [Full Text] [Related]
23. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India. Sukriti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK. J Gastroenterol Hepatol; 2008 Nov 12; 23(11):1710-5. PubMed ID: 18761556 [Abstract] [Full Text] [Related]
24. Low dose hepatitis B vaccination in children: benefit of low dose boosters. Milne A, Moyes CD, Dimitrakakis M. N Z Med J; 1988 Jun 08; 101(847 Pt 1):370-1. PubMed ID: 2970604 [Abstract] [Full Text] [Related]
25. Antibody response to half dose hepatitis B vaccine. Chan SH, Tobias MI. N Z Med J; 1987 Sep 09; 100(831):570. PubMed ID: 2967451 [No Abstract] [Full Text] [Related]
26. Post vaccination status in health care workers. Loomba PS, Thakur A, Mishra B, Dogra V. J Commun Dis; 2007 Sep 09; 39(3):205-7. PubMed ID: 18697588 [No Abstract] [Full Text] [Related]
27. [Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the Case-Essalud National Hospital, Arequipa September 1995-March 2002]. Campos Nizama J. Rev Gastroenterol Peru; 2005 Sep 09; 25(2):141-9. PubMed ID: 16021199 [Abstract] [Full Text] [Related]
28. Active hepatitis B immunization with an experimental German vaccine. IV. Reactogenicity studies in healthy adults and in hemodialysis patients. Scheiermann N, Kuwert EK. Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug 09; 257(3):456-65. PubMed ID: 6485640 [Abstract] [Full Text] [Related]
29. A two dose combined hepatitis A and B vaccine in Chinese youngsters. Lee SD, Chan CY, Yu MI, Wang YJ, Chang FY, Lo KJ, Safary A. J Med Virol; 1999 Sep 09; 59(1):1-4. PubMed ID: 10440800 [Abstract] [Full Text] [Related]
30. [Long-term observation of the immunogenicity of hepatitis B vaccine in hospital personnel]. Hayashi J, Kashiwagi S, Ikematsu H, Noguchi A, Ikeda K, Shingu T. Kansenshogaku Zasshi; 1988 Sep 09; 62(9):805-10. PubMed ID: 2974059 [No Abstract] [Full Text] [Related]
31. Hepatitis B vaccine in developing countries: problems and prospects. Ayoola EA. IARC Sci Publ; 1984 Sep 09; (63):297-305. PubMed ID: 6242148 [Abstract] [Full Text] [Related]
32. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. Hsu HY, Chang MH, Hsieh RP, Ni YH, Chi WK. Hepatology; 1996 Dec 09; 24(6):1355-60. PubMed ID: 8938161 [Abstract] [Full Text] [Related]
33. Antibody response to hepatitis B vaccine in medical & paramedical personnel in India. Sehgal A, Pavri K, Arankalle V, Jhala CI, Dhorje SP, Ramamoorthy CL. Indian J Med Res; 1987 Mar 09; 85():231-4. PubMed ID: 2956189 [No Abstract] [Full Text] [Related]
34. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal). Coursaget P, Deciron F, Tortey E, Barin F, Chiron JP, Yvonnet B, Diouf C, Denis F, Diop-Mar I, Correa P. IARC Sci Publ; 1984 Mar 09; (63):319-35. PubMed ID: 6242150 [Abstract] [Full Text] [Related]
35. Persistence of anti-HBs after intradermal inoculation of reduced doses of hepatitis B vaccine. Zoulek G, Lorbeer B, Jilg W, Deinhardt F. Lancet; 1984 Oct 27; 2(8409):983-4. PubMed ID: 6149374 [No Abstract] [Full Text] [Related]
36. [Effects of hepatitis B vaccine in neonates: induction of an anti-HBs immune response and interruption of maternal HBsAg transmission]. Wang YJ. Zhonghua Yi Xue Za Zhi; 1984 Dec 27; 64(12):741-4, 792. PubMed ID: 6242233 [No Abstract] [Full Text] [Related]
37. The dose of hepatitis B vaccine. Seville P. N Z Med J; 1988 Nov 09; 101(857):774. PubMed ID: 2972946 [No Abstract] [Full Text] [Related]
38. Hepatitis B vaccine: persistence of antibody following immunization. Barnas GP, Hanacik LJ. Infect Control Hosp Epidemiol; 1988 Apr 09; 9(4):147-50. PubMed ID: 2966192 [Abstract] [Full Text] [Related]
39. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E, Quinn TC. Arch Intern Med; 1993 Jul 26; 153(14):1705-12. PubMed ID: 8333808 [Abstract] [Full Text] [Related]
40. Hepatitis B vaccine use in chronic hemodialysis centers in the United States. Alter MJ, Favero MS, Maynard JE. JAMA; 1985 Dec 13; 254(22):3200-2. PubMed ID: 2933534 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]